NCT05468359
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05468359
Title Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Methodist Le Bonheur Healthcare WITHDRAWN Germantown Tennessee 38138 United States Details
St. Jude Children's Research Hospital RECRUITING Memphis Tennessee 38105 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field